All Curated Mutation Sites in ZIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in ZIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
M
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  
FWR
  

Keyword: NS1
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 37891235 A188V
NS1
NS1
Zika virus infection
G
R
S
L
View
2 28876359 A188V
NS1
NS1
Zika virus infection
G
View
3 28539654 M220V
NS1
NS1
Zika virus infection
R
S
C
L
View
4 28539654 U2758C
NS1
NS1
Zika virus infection
R
S
C
L
View
5 28539654 C2774A
NS1
NS1
Zika virus infection
R
S
C
L
View
6 28539654 U2781C
NS1
NS1
Zika virus infection
R
S
C
L
View
7 28539654 C2808A
NS1
NS1
Zika virus infection
R
S
C
L
View
8 28539654 C2808U
NS1
NS1
Zika virus infection
R
S
C
L
View
9 28539654 C2851U
NS1
NS1
Zika virus infection
R
S
C
L
View
10 28539654 A3061G
NS1
NS1
Zika virus infection
R
S
C
L
View
11 28539654 A3147G
NS1
NS1
Zika virus infection
R
S
C
L
View
12 28539654 V884A
NS1
NS1
Zika virus infection
R
S
C
L
View
13 28539654 N889K
NS1
NS1
Zika virus infection
R
S
C
L
View
14 28539654 W892R
NS1
NS1
Zika virus infection
R
S
C
L
View
15 28539654 P901T
NS1
NS1
Zika virus infection
R
S
C
L
View
16 28539654 P901S
NS1
NS1
Zika virus infection
R
S
C
L
View
17 28539654 S915L
NS1
NS1
Zika virus infection
R
S
C
L
View
18 28539654 K985R
NS1
NS1
Zika virus infection
R
S
C
L
View
19 28539654 M1014V
NS1
NS1
Zika virus infection
R
S
C
L
View
20 28198446 T233A
NS1
NS1
Microcephaly
R
S
View
21 39561198 E142K
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
22 39561198 R276Q
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
23 39561198 R324W
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
24 28196656 K265E
NS1
NS1
Cell line
R
View
25 31434319 R103K
NS1
NS1
Cell line
G
R
S
L
View
26 33198111 G894A
NS1
NS1
Cell line
G
R
L
View
27 33052957 A982V
NS1
NS1
Cell line
G
R
L
View
28 33052957 G894A
NS1
NS1
Cell line
G
R
L
View
29 37068347 M264V
NS1
NS1
Cell line
G
R
L
View
30 28514450 A188V
NS1
NS1
Cell line
G
R
L
View
31 36367083 A982V
NS1
NS1
Cell line
G
R
S
C
L
View
32 31547297 N130A
NS1
NS1
Cell line
G
View
33 31547297 N207A
NS1
NS1
Cell line
G
View
34 29379028 A188V
NS1
NS1
Cell line
R
I
L
T
View
35 29379028 V188A
NS1
NS1
Cell line
R
I
L
T
View
36 30763872 W98G
NS1
NS1
Cell line
L
View
37 34745057 M220I
NS1
NS1
Cell line
R
View
38 34745057 G3149A
NS1
NS1
Cell line
R
View
39 30144463 G2913A
NS1
NS1
Cell line
G
R
L
View
40 30144463 E142K
NS1
NS1
Cell line
G
R
L
View
41 33910950 R103K
NS1
NS1
Cell line
R
S
L
View
42 36968111 T139A
NS1
NS1
Cell line
I
View
43 31882898 E146K
NS1
NS1
Cell line
R
L
View
44 31882898 A233T
NS1
NS1
Cell line
R
L
View
45 31882898 G2681A
NS1
NS1
Cell line
R
L
View
46 31882898 T2724C
NS1
NS1
Cell line
R
L
View
47 31882898 G2925A
NS1
NS1
Cell line
R
L
View
48 31882898 G3059A
NS1
NS1
Cell line
R
L
View
49 31882898 T3137C
NS1
NS1
Cell line
R
L
View
50 31882898 A3140G
NS1
NS1
Cell line
R
L
View
51 31882898 G3186A
NS1
NS1
Cell line
R
L
View
52 31882898 T3218A
NS1
NS1
Cell line
R
L
View
53 31882898 G3332A
NS1
NS1
Cell line
R
L
View
54 31809512 M349K
NS1
NS1

G
R
I
L
View
55 31809512 T233A
NS1
NS1

G
R
L
View
56 31809512 W98G
NS1
NS1

G
R
L
View
57 31809512 W98R
NS1
NS1

G
R
L
View
58 31809512 Y122H
NS1
NS1

G
R
L
View
59 31809512 A188V
NS1
NS1

G
R
L
View
60 31809512 G100A
NS1
NS1

G
R
L
View
61 31809512 M349V
NS1
NS1

G
R
L
View
62 31809512 R324W
NS1
NS1

G
R
L
View
63 31809512 V264M
NS1
NS1

G
R
L
View
Contents
Description

The table shows all curated mutation sites of ZIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.